Healthcare provider profile · identity verified

Robert Ballough, P.A.

Physician Assistant · EAST HARTFORD, CT · NPI 1851551972

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	175	47
Amlodipine Besylate	Amlodipine Besylate	122	40
Gabapentin	Gabapentin	101	16
Levothyroxine Sodium	Levothyroxine Sodium	90	22
Lisinopril	Lisinopril	90	27
Metformin Hcl	Metformin Hcl	88	28
Albuterol Sulfate Hfa	Albuterol Sulfate	84	27
Pantoprazole Sodium	Pantoprazole Sodium	83	18
Hydrochlorothiazide	Hydrochlorothiazide	65	22
Tamsulosin Hcl	Tamsulosin Hcl	64	11
Ibuprofen	Ibuprofen	59	21
Losartan Potassium	Losartan Potassium	59	11
Tramadol Hcl	Tramadol Hcl	51	suppressed
Rosuvastatin Calcium	Rosuvastatin Calcium	48	18
Metoprolol Tartrate	Metoprolol Tartrate	44	11
Metformin Hcl Er	Metformin Hcl	42	12
Pravastatin Sodium	Pravastatin Sodium	39	suppressed
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	38	suppressed
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	38	13
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	37	13
Fluticasone Propionate	Fluticasone Propionate	37	15
Metoprolol Succinate	Metoprolol Succinate	36	suppressed
Montelukast Sodium	Montelukast Sodium	36	suppressed
Allopurinol	Allopurinol	35	11
Omeprazole	Omeprazole	35	suppressed
Tizanidine Hcl	Tizanidine Hcl	35	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	34	suppressed
Levetiracetam	Levetiracetam	34	suppressed
Famotidine	Famotidine	29	suppressed
Simvastatin	Simvastatin	29	suppressed
Januvia	Sitagliptin Phosphate	26	suppressed
Quetiapine Fumarate	Quetiapine Fumarate	26	suppressed
Methocarbamol	Methocarbamol	24	suppressed
Pregabalin	Pregabalin	24	suppressed
Ropinirole Hcl	Ropinirole Hcl	23	suppressed
Meloxicam	Meloxicam	22	suppressed
Mirtazapine	Mirtazapine	22	suppressed
Nebivolol Hcl	Nebivolol Hcl	21	suppressed
Glipizide Er	Glipizide	20	suppressed
Lidocaine	Lidocaine	20	suppressed
Triamcinolone Acetonide	Triamcinolone Acetonide	19	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	19	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	18	suppressed
Symbicort	Budesonide/Formoterol Fumarate	18	suppressed
Esomeprazole Magnesium	Esomeprazole Magnesium	17	suppressed
Glimepiride	Glimepiride	17	suppressed
Trulicity	Dulaglutide	17	suppressed
Azithromycin	Azithromycin	16	16
Baclofen	Baclofen	16	suppressed
Furosemide	Furosemide	16	suppressed
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	16	suppressed
Warfarin Sodium	Warfarin Sodium	16	suppressed
Ammonium Lactate	Ammonium Lactate	15	suppressed
Ezetimibe	Ezetimibe	15	suppressed
Methylprednisolone	Methylprednisolone	15	14
Mometasone Furoate	Mometasone Furoate	15	suppressed
Buspirone Hcl	Buspirone Hcl	14	suppressed
Duloxetine Hcl	Duloxetine Hcl	14	suppressed
Lubiprostone	Lubiprostone	14	suppressed
Naproxen	Naproxen	14	suppressed
Sertraline Hcl	Sertraline Hcl	14	suppressed
Topiramate	Topiramate	14	suppressed
Trazodone Hcl	Trazodone Hcl	14	suppressed
Alcohol Pads	Alcohol Antiseptic Pads	13	suppressed
Alendronate Sodium	Alendronate Sodium	13	suppressed
Alprazolam	Alprazolam	13	suppressed
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	13	suppressed
Clopidogrel	Clopidogrel Bisulfate	13	suppressed
Easy Comfort Pen Needle	Pen Needle, Diabetic	13	suppressed
Eliquis	Apixaban	13	suppressed
Fluoxetine Hcl	Fluoxetine Hcl	13	suppressed
Humalog Kwikpen U-100	Insulin Lispro	13	suppressed
Janumet	Sitagliptin Phos/Metformin Hcl	13	suppressed
Potassium Chloride	Potassium Chloride	13	suppressed
Tresiba Flextouch U-100	Insulin Degludec	13	suppressed
Valsartan	Valsartan	13	suppressed
Bupropion Hcl Sr	Bupropion Hcl	12	suppressed
Meclizine Hcl	Meclizine Hcl	12	suppressed
Amlodipine-Olmesartan	Amlodipine Bes/Olmesartan Med	11	suppressed
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	11	suppressed
Diclofenac Sodium	Diclofenac Sodium	11	suppressed
Donepezil Hcl	Donepezil Hcl	11	suppressed
Ketoconazole	Ketoconazole	11	suppressed
Ozempic	Semaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error